摘要

<正>Over the past decades, epidemiological evidence has documented risk factors of coronary artery disease (CAD), leading to extraordinary progress in understanding, preventing, and treating CAD. Nevertheless, CAD remains the top cause of mortality worldwide. The residual cardiovascular risk beyond these established factors has motivated the discovery of novel targets for risk reduction and effective treatment. The human gut microbial ecosystem,